PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Bispebjerg and Frederiksberg
About this trial
The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion
Eligibility criteria
Qualifiers
Must be able to give an informed written consent.
Must be newly accepted in the pre-planned BPD treatment packages.
≥18 years of age.
Agreeing to involvement of one or two informal caregivers, families, or close friends ("Relatives").
Disqualifiers
None*
Note that to get accepted into a treatment package for BPD, patients must not fulfill the criteria for a F20 diagnosis or the criteria for alcohol or substance abuse or harmful use.
Must be able to give an informed written consent.
≥18 years of age.
Trial design
Treatments tested in this trial
- The experimental intervention PEGASUS
- Treatment as usual
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
University Hospital Bispebjerg and Frederiksberg
Lead sponsor
Hvidovre University Hospital
Collaborator
Source ClinicalTrials.gov